文献速递临床免疫分子诊断

寨卡与登革病毒鉴别血清学诊断的综合评价

Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
PubMed 文献 · J Clin Microbiol · 2019-02-27

该回顾性研究采用非感染性野生型病毒样颗粒和可溶性NS1抗原的IgM抗体捕获ELISA,评估寨卡与登革病毒感染的鉴别诊断。FP-VLP-MAC-ELISA与NS1-MAC-ELISA的灵敏度和特异性均高于80%,两者联合准确率可达95%,可替代中和试验用于实验室筛查。

要点

  • FP-VLP与NS1联合MAC-ELISA鉴别寨卡与登革的准确率可达95%。
  • FP-VLP-MAC-ELISA和NS1-MAC-ELISA灵敏度与特异性均高于80%。
  • 该方法可在无中和试验条件的登革流行区辅助寨卡实验室筛查。

核心结论

  • FP-VLP与NS1联合MAC-ELISA可有效鉴别寨卡与登革病毒感染,准确率可达95%。

研究设计与样本

  • 回顾性研究设计,采用双途径收集人血清样本。
  • 所有血清样本均用非感染性野生型病毒样颗粒和可溶性NS1抗原的MAC-ELISA进行检测。

主要发现

  • 寨卡野生型VLP与NS1的MAC-ELISA检测抗前膜/包膜和NS1抗体的灵敏度相似,但对登革2/3型NS1交叉反应较低。
  • 组交叉反应抗体消除的同源融合肽突变VLP的阳性/阴性值持续高于同源野生型VLP。
  • FP-VLP-MAC-ELISA和NS1-MAC-ELISA的灵敏度与特异性均高于80%,两者间无统计学显著性差异。
  • FP-VLP与NS1联合检测的准确率可达95%。

关键数值与推荐

  • FP-VLP-MAC-ELISA和NS1-MAC-ELISA的灵敏度与特异性均高于80%。
  • FP-VLP与NS1联合检测的准确率可达95%。

临床怎么用

  • 可采用登革2/3型和寨卡FP-VLP建立血清学算法以鉴别寨卡与登革感染。
  • 在登革流行且无中和试验能力的地区,该方法可促进寨卡感染的实验室筛查。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diagnostic testing for Zika virus (ZIKV) or dengue virus (DENV) infection can be accomplished by a nucleic acid detection method; however, a negative result does not exclude infection due to the low virus titer during infection depending on the timing of sample collection. Therefore, a ZIKV- or DENV-specific serological assay is essential for the accurate diagnosis of patients and to mitigate potential severe health outcomes. A retrospective study design with dual approaches of collecting human serum samples for testing was developed. All serum samples were extensively evaluated by using both noninfectious wild-type (wt) virus-like particles (VLPs) and soluble nonstructural protein 1 (NS1) in the standard immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA). Both ZIKV-derived wt-VLP- and NS1-MAC-ELISAs were found to have similar sensitivities for detecting anti-premembrane/envelope and NS1 antibodies from ZIKV-infected patient sera, although lower cross-reactivity to DENV2/3-NS1 was observed. Furthermore, group cross-reactive (GR)-antibody-ablated homologous fusion peptide-mutated (FP)-VLPs consistently showed higher positive-to-negative values than homologous wt-VLPs. Therefore, we used DENV-2/3 and ZIKV FP-VLPs to develop a novel, serological algorithm for differentiating ZIKV from DENV infection. Overall, the sensitivity and specificity of the FP-VLP-MAC-ELISA and the NS1-MAC-ELISA were each higher than 80%, with no statistical significance. The accuracy can reach up to 95% with the combination of FP-VLP and NS1 assays. In comparison to current guidelines using neutralization tests to measure ZIKV antibody, this approach can facilitate laboratory screening for ZIKV infection, especially in regions where DENV infection is endemic and capacity for neutralization testing does not exist.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Chao DY, Whitney MT, Davis BS, et al. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections. J Clin Microbiol. 2019. PMID: 30541932. doi:10.1128/JCM.01506-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。